Hsa-miR-217 is also able to inhibit the proliferation, migration and invasion of NSCLC cells by targeting p53/KAI1 signal.[35] Park et al[36] suggested that PBK reduces paclitaxel-induced autophagy cell death by inhibiting p53 in NSCLC cells. The gene discussed is CD82; the disease is non-small cell lung carcinoma.